Alzheimer's Early Detection Tools Exist, But Health Systems Fail to Deliver
At the MindShift policy dialogue in Rome, dementia experts and policymakers from 12 European countries discussed the gap between scientific advances in Alzheimer's detection and the health systems' ability to deliver early diagnosis. Mercè Boada Rovira of the ACE Alzheimer Centre in Barcelona stated that 53% of Alzheimer's cases in Europe go undetected. While blood-based biomarkers like p-tau217 can now detect the disease years before symptoms appear, and new anti-amyloid drugs are only effective in early stages, most patients are diagnosed too late. Experts called for standardized testing protocols, increased funding, and systemic transformation to close the detection gap. The average wait for a dementia diagnosis in Europe is 3 to 3.5 years. The article also highlights the role of cognitive reserve and the disproportionate burden of care on women and migrant workers.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection